Novartis AG is 158.4x more valuable than Stoke Therapeutics, Inc. by market capitalization ($283.13 B vs $1.79 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | STOK | NVS |
|---|---|---|
| Market cap | $1.79 B | $283.13 B |
| US-listed rank | #2180 | #47 |
| Revenue (latest FY) | $184.42M | - |
| Net income (latest FY) | -$6.88M | - |
| Net margin | -3.7% | - |
| SEC filings | 588 | 947 |
Novartis AG is 158.4x more valuable than Stoke Therapeutics, Inc. by market capitalization ($283.13 B vs $1.79 B).
Full pages: Stoke Therapeutics, Inc. and Novartis AG, or browse the full rankings.